Sergiy Yarmoluk, The Head of Medicinal Chemistry Department of IMBG, NAS of Ukraine

Sergiy Yarmoluk has great experience in cooperating with western scientific and commercial partners. He supervised scientific contracts with Fluka GmbH (Switzerland), Enzo and Bio-Rad which resulted in patenting and releasing innovative products. He supervised a successful scientific contract with the Adamed pharmaceutical company which deals with searching for new kinase inhibitors as potential anticancer and antiviral drugs.

The scientific activity of Sergiy Yarmoluk is mainly focused on the development of fluorescent dyes for application in diagnostic systems and rational design of highly active and selective enzyme inhibitors using the methods of computer modeling, biochemical screening and organic synthesis.

There is currently no content classified with this term.